<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01401764</url>
  </required_header>
  <id_info>
    <org_study_id>B2271022</org_study_id>
    <secondary_id>2011-000419-15</secondary_id>
    <nct_id>NCT01401764</nct_id>
  </id_info>
  <brief_title>Study Comparing The Tolerability Of Three Excipient Formulations Administered Subcutaneously To Healthy Subjects</brief_title>
  <official_title>Randomized, Double Blind, Crossover, Single Centre Study Comparing The Tolerability Of Three Excipient Formulations Administered Subcutaneously To Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ablynx</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ablynx</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare local pain experienced after subcutaneous injection of
      three excipient buffers for delivering protein drugs.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Relative perception of pain of platform II versus PASS using a likert scale</measure>
    <time_frame>0 minute after injections</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Relative perception of pain of platform II versus PASS using a likert scale</measure>
    <time_frame>2 minute after injections</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Relative perception of pain of PASS versus Arg 100 using a likert scale</measure>
    <time_frame>0 minute after injections</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Relative perception of pain of PASS versus Arg 100 using a likert scale</measure>
    <time_frame>2 minute after injections</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Perception of pain of Platform II, PASS and Arg 100 using VAS scale.</measure>
    <time_frame>0 minute after injections</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Perception of pain of Platform II, PASS and Arg 100 using VAS scale.</measure>
    <time_frame>2 minute after injections</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Perception of burning of Platform II, PASS and Arg 100 using VAS scale.</measure>
    <time_frame>0 minute after injections</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Perception of burning of Platform II, PASS and Arg 100 using VAS scale.</measure>
    <time_frame>2 minute after injections</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Platform II, PASS, ARG 100</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Formulation buffers</intervention_name>
    <description>Platform II: Histidine, Polysorbate-80 PASS: Phosphate, Arginine, NaCl ARG 100: Phosphate, 100 mM Arginine</description>
    <arm_group_label>Platform II, PASS, ARG 100</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male or female subjects(no clinically relevant abnormalities identified by a
             detailed medical history, full physical examination, including blood pressure and
             pulse rate measurement, 12 lead ECG and clinical laboratory.

          -  Body mass index of 17.5 to 30.5 kg/m2; and a total body weight &gt; 50 kg (110 lbs).

        Exclusion Criteria:

          -  Any significant cardiovascular, hepatic, renal, respiratory, gastrointestinal,
             endocrine, immunologic, dermatologic, hematologic, neurologic, or psychiatric disease.

          -  Acute disease state (e.g., nausea, vomiting, fever, or diarrhea) within 7 days before
             study day 1.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Josefin-Beate Holz</last_name>
    <role>Study Director</role>
    <affiliation>Ablynx</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Investigational Site</name>
      <address>
        <city>Bruxelles</city>
        <zip>B-1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 12, 2011</study_first_submitted>
  <study_first_submitted_qc>July 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 25, 2011</study_first_posted>
  <last_update_submitted>January 30, 2013</last_update_submitted>
  <last_update_submitted_qc>January 30, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

